FLGT as of Nov 4 · 04:09 ET
FLGTNasdaqServices-Medical Laboratories
Fulgent Genetics, Inc. · Brief
Next report
2 days
Nov 6 · before openest.Q3 FY26
Expected move
Inputs5 of 8≥ implied
- avg implied
- ±11.8%
- avg realized
- ±15.2%
Nov 8 '24±8.8%▼−11.76%×1.34
Feb 28 '25±15.1%▼−1.53%×0.10
May 2 '25±11.5%▲+19.07%×1.66
Aug 1 '25±10.4%▲+7.86%×0.75
Nov 7 '25±6.7%▲+18.15%×2.71
Feb 27 '26±11.3%▼−38.09%×3.37
Q1 FY26±17.8%▼−6.98%×0.39
Q2 FY26±12.9%▼−18.11%×1.41
quarterimplied−40%0+40%realized×
Q2 FY26±12.9%▼−18.11%×1.41
Q1 FY26±17.8%▼−6.98%×0.39
Feb '26±11.3%▼−38.09%×3.37
Nov '25±6.7%▲+18.15%×2.71
Aug '25±10.4%▲+7.86%×0.75
May '25±11.5%▲+19.07%×1.66
2 older reports
Feb '25±15.1%▼−1.53%×0.10
Nov '24±8.8%▼−11.76%×1.34
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 6 report · est.Bull2 of 3
Bear2
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
FLGT report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.